Article | May 20, 2020

Improving The Patient Experience Without Sacrificing Quality Of Care

ebook1

Oncology drugs have rapidly evolved, but the delivery technology has not changed as quickly. While intravenous-based (IV) therapies are effective, they require patients to spend hours in an infusion center. In an effort to change how IV- and syringe-based oncology drug treatments are administered, West’s SmartDose® platform is available to expand patient access to SC delivery via a large-volume device that attaches to the patient. This gives the patient more freedom of movement at the center or allows administration to occur at a different location altogether.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

West Pharmaceutical Services, Inc.